Literature DB >> 15065082

Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia.

Yoshiyuki Kakehi1, Takehiko Segawa, Xiu-Xian Wu, Prakash Kulkarni, Rajiv Dhir, Robert H Getzenberg.   

Abstract

BACKGROUND: Macrophage inhibitory cytokine-1 (MIC-1) is a member of transforming growth factor-beta/bone morphogenetic protein (BMP) superfamily. Despite its potential role in prostatic regulation, little is known about its biological activity.
METHODS: Expression profiling using 42K Affymetrix HuGeneFL array was conducted to compare symptomatic benign prostatatic hyperplasia (BPH), histological BPH without symptoms, and normal prostate samples from donors. MIC-1 gene expression was analyzed by RT-PCR in pure culture of prostate epithelial and stromal cells, and prostate cancer cells, LNCaP, PC-3, DU-145. Influence of androgens on MIC-1 expression in LNCaP cells was analyzed by Northern blot. Enhancement of promoter activity of MIC-1 by androgens was examined using reporter assays.
RESULTS: In contrast to normal prostates, MIC-1 gene was down-regulated in BPH samples with symptoms and histological BPH obtained from cystoprostatectomy specimens (P < 0.005 and P < 0.01, respectively). Expression level of MIC-1 in androgen-sensitive LNCaP cells was high and enhanced by androgens, whereas in the androgen-insensitive PC-3 and DU-145 cells the expression level was low. An 11 kb promoter region of MIC-1 gene was identified to be 6- to 12-fold activated by androgens.
CONCLUSIONS: Down-regulation of MIC-1 may play a role in the development of BPH. MIC-1 is positively regulated by androgens, but other regulatory factors remain unclear. Copyright 2004 Wileey-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065082     DOI: 10.1002/pros.10365

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

Review 1.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

Review 2.  Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

3.  GDF-15 in Pulmonary and Critical Care Medicine.

Authors:  Fien M Verhamme; Christine M Freeman; Guy G Brusselle; Ken R Bracke; Jeffrey L Curtis
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

4.  Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

Authors:  Zehra Berberoglu; Aynur Aktas; Yasemin Fidan; Ayse Canan Yazici; Yalcin Aral
Journal:  J Bone Miner Metab       Date:  2014-01-16       Impact factor: 2.626

5.  Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia.

Authors:  Kazutoshi Fujita; Charles M Ewing; Robert H Getzenberg; J Kellogg Parsons; William B Isaacs; Christian P Pavlovich
Journal:  Prostate       Date:  2010-04-01       Impact factor: 4.104

Review 6.  Growth factors in benign prostatic hyperplasia: basic science implications.

Authors:  M Scott Lucia; James R Lambert
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

7.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01

Review 8.  Inflammation and benign prostatic hyperplasia.

Authors:  J Curtis Nickel
Journal:  Urol Clin North Am       Date:  2008-02       Impact factor: 2.241

9.  Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.

Authors:  Jennifer L St Sauver; Steven J Jacobsen
Journal:  Curr Prostate Rep       Date:  2008-05-01

10.  Etiopathogenesis of benign prostatic hypeprlasia.

Authors:  Jie Tang; Jingchun Yang
Journal:  Indian J Urol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.